MENU

ATHE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alterity Therapeutics (ATHE) Ownership - Who owns Alterity Therapeutics?

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

350 Collins Street

Phone

+61 393494906

Employees

9

Web

https://www.alteritytherapeutics.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

89.91M

P/E Ratio

N/A

Total Cash

49.2M

Projected Growth

N/A

Total Debt

98.45K

Revenue

N/A

Risk (Beta)

0.04

Dividend Yield

N/A

Total Cash/Share

2.71

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

ATHE

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ATHE

A.I. Advisor

published General Information

General Information

a developer of therapeutic drugs

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

350 Collins Street

Phone

+61 393494906

Employees

9

Web

https://www.alteritytherapeutics.com